The Blood Stops Here.™
Our vision is to achieve zero preventable deaths due to blood loss.
Tricol Biomedical Receives NIH Phase IIB
Grant to Continue Development of its Hemostatic Device for the Prostate.
Tricol Is Focused On Saving Lives Through Innovation In Hemostasis. Stop The Bleed!
Tricol Biomedical is a fully integrated medical device company that is dedicated to significantly advancing the standard of care in hemostatic and wound care management. Born on the battlefield, our HemCon product line has grown to meet market needs in Trauma Management, Procedural Care and Consumer Self-Care. We are fully committed to quality and innovation in bleeding control and wound care technology.
HemCon has been a long-standing pioneer in battlefield and pre-hospital hemostasis. In 2001, HemCon partnered with the U.S. Army to design a hemostatic dressing that would save the lives of soldiers who suffered traumatic injuries.Learn More
Tricol offers unique, non-invasive solutions to quickly and safely control bleeding for medical procedures in Acute Care settingsLearn More
Tricol Biomedical is addressing the consumer market by making available more bleeding control products with over-the-counter access.Learn More
The Science Behind Our Products
HemCon® PRO hemostatic products possess hemostatic activity that results from strong polycationic (positive) charge from the incorporated HemCon PRO chitosan. This positive charge correspondingly promotes binding with biopolymers, tissues, and cells possessing inherent negative charge.Learn More
Enabling Hemostasis and the Natural Coagulation Pathway
Hemostatic HemCon PRO dressings from Tricol Biomedical quickly enable hemostasis and allow the body to naturally journey through the coagulation pathway in order to clot.Learn More